Dr. Vijay Vidyasagar, MD, MPH

Dr. Vidyasagar practices at Swedish Medical Center -First Hill in Seattle, Washington.

Dr. Vidyasagar's NPI, 1487857579, was assigned on June 7, 2007. Dr. Vidyasagar holds Washington license MD60561215.

Dr. Vidyasagar's primary practice is Swedish Medical Center -First Hill, at 747 Broadway, Seattle, WA 98122 in King County. The practice phone is (206) 386-6000.

Dr. Vidyasagar's primary practice is Swedish Medical Center -First Hill in Seattle, Washington. Dr. Vidyasagar is also affiliated with Swedish First Hill Campus. The medical group on file is University Health Associates. Dmand AI also links Dr. Vidyasagar to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vidyasagar practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Vidyasagar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Vidyasagar is licensed in Washington.

CMS data shows 326 Medicare services from Dr. Vidyasagar across 4 procedure codes in 2024, for 80 Medicare patients. Medicare paid $35,073 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Vidyasagar in 2024. The largest group is under 65, with 52 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 7.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vidyasagar's median patient age at 63, with 33% women.

In 2024, Dr. Vidyasagar wrote 670 Medicare Part D claims for 76 patients. 90% of them were for generic drugs. CMS names the drug for 503 of them, across 15 drugs with 11 or more claims each, at $36,390 in total drug cost. In 2023, CMS named 323 claims across 13 drugs.

Dr. Vidyasagar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vidyasagar as offering telehealth.

Dmand AI links 4 papers to Dr. Vidyasagar, published from 2011 to 2013. The most frequent topics are Graft Rejection, Graft Survival and HLA Antigens. Dr. Vidyasagar's most frequent co-authors are David P. Foley, MD, John D. Pirsch, MD and Janet M. Bellingham, MD.

Dmand AI links Dr. Vidyasagar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Hypertension and Vascular Diseases.

CMS Open Payments shows 2 general payments to Dr. Vidyasagar from 2 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 74% of the total. Abbvie Inc. paid the most, $115.